Your session is about to expire
← Back to Search
Clinical Pathway Intervention for Pediatric Respiratory Conditions (SIP Trial)
N/A
Recruiting
Led By Sunitha V Kaiser, MD, MSc
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Primary diagnosis of asthma AND age >2 to <18 years-old at time of admission to the hospital
Primary diagnosis of pneumonia AND age >2 months and <18 years at time of admission to the hospital
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days after hospital discharge
Awards & highlights
SIP Trial Summary
This trial will test whether a multi-condition clinical pathway intervention can help community hospitals improve care for children with asthma, pneumonia, or bronchiolitis.
Who is the study for?
This trial is for children hospitalized with asthma (ages 2-18), pneumonia (ages 2 months to <18 years), or bronchiolitis (<2 years old) in community hospitals. It excludes those with COVID-19, chronic illnesses like lung or heart disease, neurologic disorders, or transfers from other inpatient facilities.Check my eligibility
What is being tested?
The study tests a multi-condition clinical pathway intervention aimed at increasing clinicians' use of evidence-based practices for treating asthma, pneumonia, and bronchiolitis over two years. The trial randomly assigns hospitals to either the new pathway or control group.See study design
What are the potential side effects?
Since this trial focuses on implementing care pathways rather than direct medical treatments, it does not have traditional side effects. However, there may be indirect impacts on patient care outcomes such as length of stay and readmission rates.
SIP Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have asthma and am between 2 and 18 years old.
Select...
I was diagnosed with pneumonia and am between 2 months and 18 years old.
Select...
My child was diagnosed with bronchiolitis and is under 2 years old.
SIP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 days after hospital discharge
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days after hospital discharge
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Asthma Evidence Based Practice 1
Asthma Evidence Based Practice 2
Asthma Evidence Based Practice 3
+4 moreSecondary outcome measures
30-day Hospital Readmission or Emergency Department Revisit
Length of Hospital Stay
Transfer to Intensive Care
SIP Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Multi-condition Pathway InterventionExperimental Treatment1 Intervention
The multi-condition pathway intervention consists of pathways clinicians select from to guide the care of children with asthma, pneumonia, or bronchiolitis. Key implementation strategies include audit and feedback, plan-do-study-act cycles, and electronic order sets.
Group II: Standard of CareActive Control1 Intervention
Hospitals randomized to the control arm will not receive the multi-condition pathway intervention or any external supports for implementation. They will continue to provide current standards of care.
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,506 Previous Clinical Trials
15,221,755 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,837 Previous Clinical Trials
47,834,794 Total Patients Enrolled
7 Trials studying Bronchiolitis
34,643 Patients Enrolled for Bronchiolitis
Society of Hospital MedicineOTHER
5 Previous Clinical Trials
7,354 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have asthma and am between 2 and 18 years old.I have been diagnosed with COVID-19.I was diagnosed with pneumonia and am between 2 months and 18 years old.I have a long-term illness like heart, lung, or nerve problems.My child was diagnosed with bronchiolitis and is under 2 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Multi-condition Pathway Intervention
- Group 2: Standard of Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many individuals have been enlisted to participate in this research?
"Confirmed, the details hosted on clinicaltrials.gov indicate that this research study is actively seeking participants. It was first listed April 1st 2022 and last adjusted May 25th 2022, with 16800 candidates being sought out from a single site."
Answered by AI
Are there any additional slots available to participate in this experiment?
"The clinical trial is currently accepting participants. According to the information on clinicaltrials.gov, it was initially publicized on April 1st 2022 and recently updated as of May 25th 2022."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger